Embecta (EMBC) vs Sanara MedTech (SMTI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sanara MedTech (SMTI) has outperformed Embecta (EMBC) over the past year, gaining 8.4% versus a loss of 58.4%. Sanara MedTech is the larger company by market cap ($322.2 million vs $322.1 million), about 1.0 times the size. On valuation, Embecta trades at a lower forward P/E (3.2x vs 64.9x for Sanara MedTech).
Embecta pays a dividend yielding 8.09%, while Sanara MedTech does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMBC | SMTI |
|---|---|---|
| Share price | $5.69 | $35.07 |
| Market cap | $322.11M | $322.22M |
| 1-day change | -1.13% | +0.06% |
| YTD return | -51.60% | +50.11% |
| 1-year return | -58.39% | +8.41% |
| 5-year return | — | +6.28% |
| P/E ratio (TTM) | 3.87 | — |
| Forward P/E | 3.23 | 64.94 |
| EPS (TTM) | $1.47 | $-0.04 |
| Dividend yield | 8.09% | 0.00% |
| Annual dividend | $0.46 | $0.00 |
| 52-week high | $14.91 | $35.34 |
| 52-week low | $2.77 | $16.05 |
| Distance from 52-week high | -61.87% | -0.76% |
| Analyst consensus | none | none |
| Avg. price target upside | -29.64% | -0.20% |
| Average volume | 1.37M | 280.40K |
| Shares outstanding | 56.66M | 9.19M |
| Employees | 1,850 | 108 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SMTI has outperformed EMBC by 66.8 percentage points over the past year.
- Embecta offers a meaningfully higher dividend yield (8.09% vs 0.00%).
About Embecta
EMBC stock →Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes.
Health Care · Medical/Dental Instruments · 1,850 employees
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
EMBC vs SMTI FAQ
Which is bigger, Embecta or Sanara MedTech?
Sanara MedTech (SMTI) is larger, with a market capitalization of $322.22M compared with $322.11M for Embecta (EMBC).
Which stock has performed better over the past year, EMBC or SMTI?
SMTI returned +8.41% over the past 12 months, compared with -58.39% for EMBC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Embecta or Sanara MedTech?
Embecta pays a dividend yielding 8.09%, while Sanara MedTech does not currently pay a regular dividend.
Are Embecta and Sanara MedTech in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Embecta and Industrial Specialties for Sanara MedTech.